On May 21, 2010, the IRS issued highly anticipated rules on the Qualifying Therapeutic Discovery Project credit. In recent advisories, we reported that the Patient Protection and Affordable Care Act (a/k/a – the health care reform bill) includes $1 billion in tax credits and grants to defray the costs of therapeutic research for small and mid-size life sciences companies, including drug, therapeutic, and diagnostic companies.
Please see full publication below for more information.